정맥내(IV) 요법 및 정맥 접근 : 세계 시장

The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.

Report Scope

This report examines the global IV therapy and vein access device market, providing a comprehensive review of applications across various healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of intravenous solutions. The report includes segments by product type and application. By product type, the market is segmented into IV solutions and sets, infusion pumps and accessories, and vein access devices (IV catheters). IV solutions and sets are categorized into general IV solutions, parenteral nutrition IV solutions, premixed drug IV solutions, and other IV solutions and sets. Infusion pumps and accessories include general infusion pumps, specialized infusion pumps, and other infusion accessories. Vein access devices cover peripheral intravenous catheters and central venous catheters.

Product inclusions for each IV solution and sets market segment:

• General IV solutions: Includes normal saline, hypertonic saline, Lactated Ringer's, Dextran, and dextrose in water used for hydration, fluid replacement, and electrolyte management.
• Parenteral nutrition IV solutions: Includes intravenous nutritional formulations containing carbohydrates, lipid emulsions, amino acids, vitamins, minerals, and trace elements.
• Premixed IV solutions: Includes ready-to-administer premixed IV drugs such as antibiotics, pain-management medications, and cardiovascular agents, supplied in IV bags, bottles, or other containers.
• Other IV solutions and sets: Includes specialized IV solutions not covered above, along with administration sets, extension sets, connectors, filters, and other IV delivery accessories.

This report addresses regulatory aspects, including innovations, technological advances (patents and approvals), and the latest trends, preferences, and developments in IV therapy. It also includes market projections, key companies, and market share analysis for the global IV therapy and vein access market. The scope also includes emerging technologies, such as advanced intraosseous infusion systems, antimicrobial-coated sets, needleless connectors, and smart vein visualization and vascular-access devices, which are expected to improve the safety, efficiency, and reliability of vascular-access procedures. The market has been segmented into major regions, including North America, Asia-Pacific, Europe, and the rest of the world (RoW). The analysis covers countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, and China.

Report Includes

• 77 data tables and 68 additional tables
• Overview of the global intravenous (IV) therapy and vein access market
• Analyses of global market trends, with revenue data for 2023-2025, estimates for 2026, and projections of CAGRs through 2031
• Evaluation of the market by product type, application, and region
• Discussion of major market drivers, restraints, challenges, and opportunities shaping the adoption of IV therapy and vein access technologies worldwide
• Review of regulatory frameworks in key countries, along with analysis of macroeconomic factors, Porter's Five Forces, and the impact of U.S. tariffs on the industry
• Regional market coverage North America, Europe, Asia-Pacific, the Middle East & Africa, and South America
• Profiles of leading companies and emerging startups, highlighting their product offerings, business strategies, and recent developments, including BD, Fresenius SE & Co. KGaA, Baxter, B. Braun SE, and Insulet Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Intravenous Therapy Overview
• Human Circulatory System
• Definition of Infusion Therapy
• Definition of Intravenous Therapy
• Types of IV Infusion
• Continuous Infusion
• Intermittent Infusion
• Patient-Controlled Infusion
• Methods of IV Infusion Pump
• Pump Infusion
• Drip Infusion
• IV Solutions
• General IV Solutions
• Parenteral Nutrition IV Solutions
• Premixed Drug IV Solutions
• IV Infusion Pumps
• Venous Access Devices (IV Catheters)
• Porter's Five Forces Analysis of the IV Therapy and Vein Access Market
• Competitive Rivalry (High)
• Threat of New Entrants (Moderate)
• Threat of Substitutes (Low)
• Bargaining Power of Buyers (High)
• Bargaining Power of Suppliers (Moderate)
• Macroeconomic Factors Analysis
• Inflation and Rising Manufacturing Costs
• Impact of the U.S.-Israel-Iran Conflict on the Intravenous Therapy and Vein Access Devices Market
• Slower Global Economic Growth and Capital Spending
• Government Healthcare Spending and Medical Device Localization

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Burden of Chronic Diseases Requiring Long-Term Infusion Therapy
• Growing Surgical Procedures and Hospital Admissions Driving Vascular Access Demand
• Rapid Expansion of Home Infusion Therapy
• Stronger Infection Prevention Guidelines Accelerating Adoption of Advanced Vein Access Technologies
• Rising Global Burden of VTE and Hospital-Acquired Infections Driving Demand for Advanced IV Therapy and Vein Access Solutions
• Expanding Global Geriatric Population
• Market Restraints
• Risk of Infections and Complications
• Regulatory Challenges in IV Therapy and Vein Access Market
• Safety and Recall Challenges in IV Therapy
• Reimbursement Policies
• Market Opportunities
• Technological Advances
• Expanding Pipeline of Infusion-Based Biologics and Specialty Therapies

Chapter 4 Regulatory Landscape

• Regulatory Scenario
• U.S.
• Europe
• Japan
• India
• China
• U.K.

Chapter 5 Emerging Trends and Technologies

• Key Takeaways
• Advances in Intraosseous Infusion Systems for Vascular Access
• Antimicrobial-Coated Sets
• Needleless Connectors
• IV Filters
• Smart Vein Visualization and Access Devices
• Smart IV Devices
• Blood Transfusion Sets
• Wireless Sensor Networks (WSN) and AI in IV Therapy
• Recent Advances in Intravenous Therapy and Vein Access
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• IV Solutions and Sets
• Infusion Pumps and Accessories
• Vein Access Devices (IV Catheters)
• Market Analysis by Application
• Key Takeaways
• Hospitals
• Alternative Sites
• Home-Based
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Landscape

• Key Takeaways
• Industry Scenario
• Global Market Shares of Leading Companies
• Acquisitions
• Strategic Alliances

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ANGIODYNAMICS
• BAXTER
• B. BRAUN SE
• BD
• CARDINAL HEALTH
• COOK MEDICAL INC.
• FRESENIUS SE & CO. KGAA
• ICU MEDICAL INC.
• INSULET CORP.
• IRADIMED CORP.
• MEDTRONIC
• PFIZER INC.
• TERUMO CORP.
• VYGON
• WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.
• Few Emerging Startups/Market Disruptors